Reported 2 months ago
Shares of McKesson Corporation declined after the company reported fiscal Q1 earnings that missed analysts' revenue expectations, primarily due to underperformance in its prescription technology solutions and US pharmaceuticals sectors. Market experts discuss the implications for the pharmaceutical distributor's future.
Source: YAHOO